# Simpler Grants.gov #PAR-28-056

NCI Solicits Research Units for Early Detection of Pancreatic Cancer

**Buyer:** National Cancer Institute (NCI)
**Posted:** September 25, 2026
**Respond By:** November 05, 2029
**Identifier:** PAR-28-056
**NAICS:** 541715, 541714

This opportunity from the National Cancer Institute (NCI) seeks multidisciplinary research teams for early detection of pancreatic cancer.
- Government Buyer:
  - National Institutes of Health (NIH), National Cancer Institute (NCI)
- Scope of Work:
  - Establish Research Units (RUs) within the Pancreatic Cancer Detection Consortium (PCDC)
  - Conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions
  - Develop and test new molecular and imaging biomarkers
  - Identify and validate biomarkers using machine learning and computational approaches
  - Collect longitudinal biospecimens to build a biorepository
  - Collaborate and share data within the Consortium
- Eligibility:
  - Open to domestic U.S. entities (government, nonprofit, business, educational organizations)
- Funding:
  - Minimum award is $600,000
- Unique Requirements:
  - No specific OEMs or vendors; this is a research grant, not a product procurement
  - Emphasis on collaboration, data sharing, and biorepository development

### Description

The National Cancer Institute (NCI) solicits applications for Research Units (RUs) as part of the Pancreatic Cancer Detection Consortium (PCDC) to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions. The research aims to develop and test new molecular and imaging biomarkers for early detection and identification of high-risk patients. The PCDC-RUs will consist of multidisciplinary teams conducting biomarker discovery, validation, and longitudinal biospecimen collection. Collaboration and data sharing among PCDC-RUs are expected to advance early intervention strategies for PDAC.

[View original listing](https://simpler.grants.gov/opportunity/361275)